Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


29.10.2018

4 BMJ
3 Clin Infect Dis
2 J Gen Virol
1 J Immunol
3 J Infect Dis
1 J Pediatr
2 J Virol
1 JAMA
1 Lancet
2 Lancet Glob Health
5 MMWR Morb Mortal Wkly Rep
1 Nat Immunol
6 PLoS One
1 Science
24 Vaccine
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ

  1. DYER O
    Chinese government fines vaccine company pound1bn for string of violations.
    BMJ. 2018;363:k4420.
    PubMed     Text format    

  2. LE P
    Which shingles vaccine for older adults?
    BMJ. 2018;363:k4203.
    PubMed     Text format    

  3. TRICCO AC, Zarin W, Cardoso R, Veroniki AA, et al
    Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis.
    BMJ. 2018;363:k4029.
    PubMed     Text format     Abstract available

  4. THORNTON J
    MPs slam "outrageous" 25% uptake of flu vaccine among social care staff.
    BMJ. 2018;363:k4423.
    PubMed     Text format    


    Clin Infect Dis

  5. PRAHARAJ I, Platts-Mills JA, Taneja S, Antony K, et al
    Diarrheal etiology and impact of co-infections on rotavirus vaccine efficacy estimates in a clinical trial of a monovalent human-bovine (116E) oral rotavirus vaccine, Rotavac, India.
    Clin Infect Dis. 2018 Oct 17. pii: 5134205. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. SINGS HL, De Wals P, Gessner BD, Isturiz R, et al
    Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-Analysis of Observational Studies.
    Clin Infect Dis. 2018 Oct 23. pii: 5142858. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. LOPEZ BERNAL JA, Andrews N, Amirthalingam G
    The use of quasi-experimental designs for vaccine evaluation.
    Clin Infect Dis. 2018 Oct 22. pii: 5140188. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Gen Virol

  8. BICKERTON E, Dowgier G, Britton P
    Recombinant infectious bronchitis viruses expressing heterologous S1 subunits: potential for a new generation of vaccines that replicate in Vero cells.
    J Gen Virol. 2018 Oct 24. doi: 10.1099/jgv.0.001167.
    PubMed     Text format     Abstract available

  9. LI J, Hou G, Wang Y, Wang S, et al
    Protective efficacy of an inactivated chimeric H5 avian influenza vaccine against H5 highly pathogenic avian influenza virus clades 2.3.4.4 and 2.3.2.1.
    J Gen Virol. 2018 Oct 25. doi: 10.1099/jgv.0.001140.
    PubMed     Text format     Abstract available


    J Immunol

  10. SHIMIZU T, Abu Lila AS, Kawaguchi Y, Shimazaki Y, et al
    A Novel Platform for Cancer Vaccines: Antigen-Selective Delivery to Splenic Marginal Zone B Cells via Repeated Injections of PEGylated Liposomes.
    J Immunol. 2018 Oct 17. pii: jimmunol.1701351. doi: 10.4049/jimmunol.1701351.
    PubMed     Text format     Abstract available


    J Infect Dis

  11. BEERNINK PT, Ispasanie E, Lewis LA, Ram S, et al
    A meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and overexpressed Factor H binding protein elicits gonococcal bactericidal antibodies.
    J Infect Dis. 2018 Oct 20. pii: 5139647. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. ROSENBERG T, Philipsen BB, Mehlum CS, Dyrvig AK, et al
    Therapeutic use of the HPV vaccine on recurrent respiratory papillomatosis: a systematic review and meta-analysis.
    J Infect Dis. 2018 Oct 25. pii: 5144565. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. ARMAH GE, Cortese MM, Dennis FE, Yu Y, et al
    Rotavirus Vaccine Take in Infants Is Associated With Secretor Status.
    J Infect Dis. 2018 Oct 24. pii: 5144065. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Pediatr

  14. HAZAN G, Dagan R, Friger M
    Maternal Education Is Inversely Related to Vaccination Delay among Infants and Toddlers.
    J Pediatr. 2018 Oct 16. pii: S0022-3476(18)31301.
    PubMed     Text format     Abstract available


    J Virol

  15. OGDEN KM, Tan Y, Akopov A, Stewart LS, et al
    Multiple introductions and antigenic mismatch with vaccines may contribute to increased predominance of G12P[8] rotaviruses in the United States.
    J Virol. 2018 Oct 17. pii: JVI.01476-18. doi: 10.1128/JVI.01476.
    PubMed     Text format     Abstract available

  16. AN Y, Parsons LM, Jankowska E, Melnyk D, et al
    N-Glycosylation of Seasonal Influenza Vaccine Hemagglutinins: Implication for potency testing and immune processing.
    J Virol. 2018 Oct 24. pii: JVI.01693-18. doi: 10.1128/JVI.01693.
    PubMed     Text format     Abstract available


    JAMA

  17. FAUCI AS
    Addressing the Tuberculosis Epidemic: 21st Century Research for an Ancient Disease.
    JAMA. 2018 Sep 26. pii: 2702934. doi: 10.1001/jama.2018.12852.
    PubMed     Text format    


    Lancet

  18. HOLT E
    41 000 measles cases in Europe since the beginning of 2018.
    Lancet. 2018;392:724.
    PubMed     Text format    


    Lancet Glob Health

  19. MASLOW JN
    The cost and challenge of vaccine development for emerging and emergent infectious diseases.
    Lancet Glob Health. 2018 Oct 17. pii: S2214-109X(18)30418.
    PubMed     Text format    

  20. GOUGLAS D, Thanh Le T, Henderson K, Kaloudis A, et al
    Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study.
    Lancet Glob Health. 2018 Oct 17. pii: S2214-109X(18)30346.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  21. MARX GE, Burakoff A, Barnes M, Hite D, et al
    Mumps Outbreak in a Marshallese Community - Denver Metropolitan Area, Colorado, 2016-2017.
    MMWR Morb Mortal Wkly Rep. 2018;67:1143-1146.
    PubMed     Text format     Abstract available

  22. JORBA J, Diop OM, Iber J, Henderson E, et al
    Update on Vaccine-Derived Polioviruses - Worldwide, January 2017-June 2018.
    MMWR Morb Mortal Wkly Rep. 2018;67:1189-1194.
    PubMed     Text format     Abstract available

  23. SINGH AJ, Chipman RB, de Fijter S, Gary R, et al
    Translocation of a Stray Cat Infected with Rabies from North Carolina to a Terrestrial Rabies-Free County in Ohio, 2017.
    MMWR Morb Mortal Wkly Rep. 2018;67:1174-1177.
    PubMed     Text format     Abstract available

  24. CHOW EJ, Davis CT, Abd Elal AI, Alabi N, et al
    Update: Influenza Activity - United States and Worldwide, May 20-October 13, 2018.
    MMWR Morb Mortal Wkly Rep. 2018;67:1178-1185.
    PubMed     Text format     Abstract available

  25. AVRAMOVICH E, Indenbaum V, Haber M, Amitai Z, et al
    Measles Outbreak in a Highly Vaccinated Population - Israel, July-August 2017.
    MMWR Morb Mortal Wkly Rep. 2018;67:1186-1188.
    PubMed     Text format     Abstract available


    Nat Immunol

  26. COCKBURN IA, Seder RA
    Malaria prevention: from immunological concepts to effective vaccines and protective antibodies.
    Nat Immunol. 2018;19:1199-1211.
    PubMed     Text format     Abstract available


    PLoS One

  27. O'MALLEY KJ, Bowling JL, Stinson E, Cole KS, et al
    Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.
    PLoS One. 2018;13:e0205928.
    PubMed     Text format     Abstract available

  28. PARK S, Lee Y, Kwon YM, Lee YT, et al
    Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge.
    PLoS One. 2018;13:e0205071.
    PubMed     Text format     Abstract available

  29. LI Z, Swann JL, Keskinocak P
    Value of inventory information in allocating a limited supply of influenza vaccine during a pandemic.
    PLoS One. 2018;13:e0206293.
    PubMed     Text format     Abstract available

  30. JACKSON ML, Diallo AO, Medah I, Bicaba BW, et al
    Initial validation of a simulation model for estimating the impact of serogroup A Neisseria meningitidis vaccination in the African meningitis belt.
    PLoS One. 2018;13:e0206117.
    PubMed     Text format     Abstract available

  31. CHIDUMAYO NN
    System dynamics modelling approach to explore the effect of dog demography on rabies vaccination coverage in Africa.
    PLoS One. 2018;13:e0205884.
    PubMed     Text format     Abstract available

  32. CAMPBELL ZA, Marsh TL, Mpolya EA, Thumbi SM, et al
    Newcastle disease vaccine adoption by smallholder households in Tanzania: Identifying determinants and barriers.
    PLoS One. 2018;13:e0206058.
    PubMed     Text format     Abstract available


    Science

  33. PONS-SALORT M, Grassly NC
    Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses.
    Science. 2018;361:800-803.
    PubMed     Text format     Abstract available


    Vaccine

  34. ATTWELL K, Navin MC, Lopalco PL, Jestin C, et al
    Recent vaccine mandates in the United States, Europe and Australia: A comparative study.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31371.
    PubMed     Text format     Abstract available

  35. RIVADENEIRA MF, Bassanesi SL, Fuchs SC
    Socioeconomic inequalities and measles immunization coverage in Ecuador: A spatial analysis.
    Vaccine. 2018;36:5251-5257.
    PubMed     Text format     Abstract available

  36. VORSTERS A, Van Damme P
    HPV immunization programs: Ensuring their sustainability and resilience.
    Vaccine. 2018;36:5219-5221.
    PubMed     Text format    

  37. AGUDELO CI, DeAntonio R, Castaneda E
    Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean 2010-2015: A systematic review and a time series analysis.
    Vaccine. 2018;36.
    PubMed     Text format     Abstract available

  38. GAMAOUN R
    National cervical cancer prevention program in the Arab States: Strategies and cost-minimization study of the Tunisian case.
    Vaccine. 2018 Jul 5. pii: S0264-410X(18)30921.
    PubMed     Text format     Abstract available

  39. PING X, Hu W, Xiong R, Zhang X, et al
    Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence.
    Vaccine. 2018 Jun 27. pii: S0264-410X(18)30889.
    PubMed     Text format     Abstract available

  40. THANG HV, Huong VM, Victor JC, Van CB, et al
    Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31365.
    PubMed     Text format     Abstract available

  41. CHIDO-AMAJUOYI OG, Wonodi C, Mantey D, Perez A, et al
    Prevalence and correlates of never vaccinated Nigerian children, aged 1-5years.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31358.
    PubMed     Text format     Abstract available

  42. SALAT J, Formanova P, Hunady M, Eyer L, et al
    Development and testing of a new tick-borne encephalitis virus vaccine candidate for veterinary use.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31400.
    PubMed     Text format     Abstract available

  43. HRABER P, Bradfute S, Clarke E, Ye C, et al
    Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31388.
    PubMed     Text format     Abstract available

  44. PERCIACCANTE A, Coralli A, Bianucci R
    Vaccines: The oxymoron of Italian health policy.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31404.
    PubMed     Text format    

  45. ZHAI Y, Santibanez TA, Kahn KE, Black CL, et al
    Paid sick leave benefits, influenza vaccination, and taking sick days due to influenza-like illness among U.S. workers.
    Vaccine. 2018 Oct 22. pii: S0264-410X(18)31405.
    PubMed     Text format     Abstract available

  46. LOEB M, Russell ML, Neupane B, Thanabalan V, et al
    A randomized, blinded, placebo-controlled trial comparing antibody responses to homeopathic and conventional vaccines in university students.
    Vaccine. 2018 Oct 20. pii: S0264-410X(18)31232.
    PubMed     Text format     Abstract available

  47. HEINSBROEK E, Tafatatha T, Phiri A, Swarthout TD, et al
    Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination.
    Vaccine. 2018 Oct 20. pii: S0264-410X(18)31387.
    PubMed     Text format     Abstract available

  48. WILLAME C, Lin L, Vetter V, Baril L, et al
    Reply to Lee et al.'s letter to the editor pertaining to our publication entitled "Pain caused by measles, mumps, and rubella vaccines: A systematic literature review".
    Vaccine. 2018;36:6589-6590.
    PubMed     Text format    

  49. LEE AW, Saldutti LP, Wolfson LJ, Stek JE, et al
    To the editor: Response to Willame, et al., published in Vaccine 35 (2017) 5551-5558, entitled "Pain caused by measles, mumps, and rubella vaccines: A systematic literature review".
    Vaccine. 2018;36:6587-6588.
    PubMed     Text format    

  50. WANG Q, Yue N, Zheng M, Wang D, et al
    Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31411.
    PubMed     Text format     Abstract available

  51. D'ALESSIO F, Koopman G, Houard S, Remarque EJ, et al
    Workshop report: Experimental animal models for universal influenza vaccines.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31390.
    PubMed     Text format     Abstract available

  52. BARTSCH SM, Taitel MS, DePasse JV, Cox SN, et al
    Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
    Vaccine. 2018 Oct 5. pii: S0264-410X(18)31300.
    PubMed     Text format     Abstract available

  53. THOMAS LF, Bellet C, Rushton J
    Using economic and social data to improve veterinary vaccine development: Learning lessons from human vaccinology.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31410.
    PubMed     Text format     Abstract available

  54. MCGAVIN ZA, Wagner AL, Carlson BF, Power LE, et al
    Childhood full and under-vaccination in Nigeria, 2013.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31409.
    PubMed     Text format     Abstract available

  55. ZHANG L, Durr E, Galli JD, Cosmi S, et al
    Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31398.
    PubMed     Text format     Abstract available

  56. SANTIBANEZ TA, Kahn KE, Bridges CB
    Do parents prefer inactivated or live attenuated influenza vaccine for their children?
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31408.
    PubMed     Text format     Abstract available

  57. CANNON JW, Jack S, Wu Y, Zhang J, et al
    An economic case for a vaccine to prevent group A streptococcus skin infections.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31352.
    PubMed     Text format     Abstract available


    Virus Res

  58. LIU X, Zhang Q, Zhang L, Zhou P, et al
    A newly isolated Chinese virulent genotype GIIb porcine epidemic diarrhea virus strain: biological characteristics, pathogenicity and immune protective effects as an inactivated vaccine candidate.
    Virus Res. 2018 Oct 17. pii: S0168-1702(18)30543.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: